Daehwa Pharm
Daehwa Pharm is a South Korean public company founded in 1984 and listed on the KOSDAQ stock market since 2002. The company operates three R&D centers and four manufacturing facilities, specializing in drug delivery systems, pharmaceutical products, and transdermal drug delivery. Daehwa Pharm has subsidiaries in Germany and China and exports to over 20 countries. Its key product is the world's first approved oral paclitaxel solution, LIPORAXEL solution. Industries it prefers include diversified conglomerates, environmental services, and renewable energy. Verticals it prefers include cleantech and electric & hybrid vehicles.